THY-Tau22 | ALZFORUM
Jan 31, 2025 · Troquier L, Caillierez M, Burnouf S, Fernandez-Gomez FJ, Grosjean MJ, Zommer N, Sergeant N, Schraen-Maschke S, Blum D, Buee L. Targeting phospho-Ser422 by active …
Neurotrophic factors in Alzheimer's disease: role of axonal …
Schindowski K, Belarbi K, Buée L.Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav. 2008 Feb;7 Suppl 1:43-56.
Tau protein isoforms, phosphorylation and role in ... - ALZFORUM
Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR.Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.
RG7345 - ALZFORUM
Nov 20, 2015 · Troquier L, Caillierez M, Burnouf S, Fernandez-Gomez FJ, Grosjean MJ, Zommer N, Sergeant N, Schraen-Maschke S, Blum D, Buee L. Targeting phospho-Ser422 by active …
Aggregate-selective removal of pathological tau by clustering …
Sep 20, 2024 · Benn J, Cheng S, Keeling S, Smith AE, Vaysburd MJ, Böken D, Miller LV, Katsinelos T, Franco C, Dupré E, Danis C, Landrieu I, Buée L, Klenerman D, James LC, …
NETWORKING FOR A CURE - ALZFORUM
Sep 6, 2022 · Education MSc @ Univ Lille, France. PhD benchwork in New York (MSMC 1989-1992) and graduate in 1992 in Lille, France
NLRP3 inflammasome activation drives tau pathology. - ALZFORUM
Nov 29, 2019 · View all comments by Hugh Perry; Dave Morgan Michigan State University; Posted: 26 Nov 2019 News: Microglia Inflammasome Stokes Tau Phosphorylation, Tangles
To Block Tau’s Proteopathic Spread, Antibody Must Attack
The French researchers injected pathological tau from AD brain into the hippocampi of young tau transgenic mice to trigger pathology. This was followed by six weekly intraperitoneal tau …
New Arrows Aimed at Tau: Single-Domain Antibody, Peptibody, …
03 May 2023. Tau pathology is proving a tough nut to crack, with most antibodies directed against it posting negative results in clinical trials thus far.
New piperazine multi-effect drugs prevent neurofibrillary …
Sergeant N, Vingtdeux V, Eddarkaoui S, Gay M, Evrard C, Le Fur N, Laurent C, Caillierez R, Obriot H, Larchanché PE, Farce A, Coevoet M, Carato P, Kouach M, Descat A ...